Renal protective effect of enalapril in diabetic nephropathy.
Reads0
Chats0
TLDR
Treatment with enalapril can reduce the rate of decline in kidney function in patients with diabetic nephropathy more than equally effective antihypertensive treatment with metoprolol, which points to a specific renal protective effect of angiotensin converting enzyme inhibitors in diabetic neephropathy.Abstract:
OBJECTIVE--To determine whether inhibition of angiotensin converting enzyme can reduce the rate of decline in kidney function more than reducing blood pressure with other antihypertensive treatment. DESIGN--Prospective, open randomised study lasting a mean of 2.2 years in patients with diabetic nephropathy. SETTING--Three outpatient nephrology clinics. PATIENTS--40 patients with insulin dependent diabetes and diabetic nephropathy with reduced renal function. INTERVENTION--Antihypertensive treatment with enalapril or metoprolol, usually combined with frusemide. MAIN OUTCOME MEASURE--Rate of decline in glomerular filtration rate measured as chromium-51 edetic acid clearance. RESULTS--Glomerular filtration rate declined a mean of 2.0 (SD 3.2) ml/min/year in the group given enalapril and 5.6 (5.9) ml/min/year in the control group. The mean arterial blood pressure during the study was 102 (5) mm Hg in the patients given enalapril and 103 (5) mm Hg in the patients given metoprolol. Urinary albumin excretion during treatment with enalapril was 60% lower than during treatment with metoprolol. CONCLUSIONS--Enalapril has an antiproteinuric effect independent of the effect on systemic blood pressure. Treatment with enalapril can reduce the rate of decline in kidney function in patients with diabetic nephropathy more than equally effective antihypertensive treatment with metoprolol. This points to a specific renal protective effect of angiotensin converting enzyme inhibitors in diabetic nephropathy.read more
Citations
More filters
Journal ArticleDOI
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
Journal ArticleDOI
Serum creatinine as an index of renal function: new insights into old concepts.
TL;DR: The fundamental principles of physiology, metabolism, and analytical chemistry that are necessary to correctly interpret the serum creatinine concentration are reviewed and applied to important clinical circumstances, including aging, pregnancy, diabetes mellitus, drug administration, and acute and chronic renal failure.
Journal ArticleDOI
Pathophysiology of Progressive Nephropathies
Giuseppe Remuzzi,Tullio Bertani +1 more
TL;DR: In patients with renal diseases characterized by proteinuria, the initial insult to the kidney is usually followed by a progressive decline in the glomerular filtration rate, which is thought to be due to changes in renal hemodynamics initiated by the loss of nephrons.
Journal ArticleDOI
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data
Tazeen H. Jafar,Christopher H. Schmid,Marcia Landa,I. Giatras,Robert D. Toto,Giuseppe Remuzzi,G. Maschio,Barry M. Brenner,A. Kamper,P. Zucchelli,Gavin J. Becker,A. Himmelmann,K. Bannister,Paul Landais,Shahnaz Shahinfar,P. E. De Jong,Dick de Zeeuw,Joseph Lau,Andrew S. Levey +18 more
TL;DR: A large number of patients in the pooled analysis would provide sufficient statistical power to detect relationships between patient characteristics and risk for progression of renal disease and interactions of patient characteristics with treatment effect, and strong and consistent results from analysis would clarify the effects of ACE inhibitors for treatment of nondiabetic renal disease.
Journal ArticleDOI
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
George L. Bakris,Matthew R. Weir +1 more
TL;DR: A strong association exists between acute increases in serum creatinine of up to 30% that stabilize within the first 2 months of ACEI therapy and long-term preservation of renal function and withdrawal of an ACEI in patients with preexisting renal insufficiency is recommended.
References
More filters
Journal ArticleDOI
A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with Hypertension
TL;DR: Hydchlorothiazide for the treatment of essential hypertension has adverse effects on glucose and lipid metabolism and it is possible, but not proved, that these changes may contribute to the risk for diabetes mellitus and coronary heart disease.
Journal ArticleDOI
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
TL;DR: It is indicated that antihypertensive treatment slows the decline in renal function in diabetic nephropathy and the optimal modality of treatment in this large patient population will be defined.
Journal ArticleDOI
Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
TL;DR: Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy and significantly reduces the rate of decline in the glomerular filtration rate.
Journal ArticleDOI
Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus.
TL;DR: Dietary restriction of protein and phosphorus can retard the progression of renal failure in patients with Type I diabetes mellitus who have nephropathy and it is believed that wider use of this treatment is indicated.
Journal ArticleDOI
Efficacy and variability of the antiproteinuric effect of ace inhibition by lisinopril
TL;DR: The antiproteinuric effect of the ACE inhibitor lisinopril appears to be dose and time related, and is strongly dependent on dietary sodium restriction, whereas it does not depend on initial proteinuria, BP, or GFR.